Navigation Links
Aware, Inc. Reports First Quarter 2013 Financial Results
Date:4/23/2013

BEDFORD, Mass., April 23, 2013 /PRNewswire/ -- Aware, Inc. (NASDAQ: AWRE), a leading supplier of biometrics software and services and DSL service assurance software products, today reported financial results for its first quarter ended March 31, 2013. 

Revenue for the first quarter of 2013 was $5.6 million, an increase of 15% compared to $4.9 million in the same quarter last year. Operating income before patent related income in the first quarter of 2013 was $2.0 million compared to $1.0 million in the first quarter of 2012.

Net income for the first quarter of 2013 was $1.9 million, or $0.08 per diluted share, which compares to net income of $1.1 million, or $0.05 per diluted share, for the same period a year ago.

Additional information regarding first quarter 2013 results is as follows:

  • The improvement in operating income before patent related income this year versus last year was primarily due to increased profitability in our biometrics and imaging business and lower general and administrative expenses.
  • Net income in the first quarter of 2013 included income from a patent arrangement of $0.8 million. This income relates to an agreement we entered into several years ago with an unaffiliated third party under which we assigned patents in return for royalties on proceeds from its patent monetization efforts. We are unable to predict how much more income we might receive from this arrangement, if any, because we do not know whether any patent monetization efforts by the third party will be successful.
  • Income tax expense for the first quarter of 2013 was $1.0 million versus $2,000 in the prior year quarter.
    Income tax expense this year was based on the U.S. statutory rate of 34%, increased by state income taxes.  Income tax expense in the first quarter of 2012 was offset by the reversal of
    '/>"/>

  • SOURCE Aware, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology news :

    1. NASDAQ Sets Ex-Dividend Date for Aware, Inc.s Special Cash Dividend of $1.80 Per Share
    2. Aware, Inc. Declares Special Cash Dividend of $1.80 Per Share, or Approximately $40 Million in Total
    3. Aware, Inc. Reports Third Quarter 2012 Financial Results
    4. Aware, Inc. Reports Second Quarter 2012 Financial Results
    5. Aware, Inc. Reports First Quarter 2012 Financial Results
    6. University of Florida reports 2012 US shark attacks highest since 2000
    7. Invading species can extinguish native plants despite recent reports
    8. Study reports iron oxide nanoparticles effective for labeling human endothelial cells
    9. Cell Transplantation reports islet cell advancement increases impact on transplantation
    10. New low carbon TINA reports
    11. Texas Biomed reports faster, more economical method for detecting bioterror threats
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/19/2015)... Research and Markets ( ... the  "Genetic Testing Market Outlook 2018"  report ... ,A recent report, Genetic Testing Market Outlook ... current and future genetic testing market. A ... principles and types are covered in this ...
    (Date:5/11/2015)... May 11, 2015  Through a well-rounded UAS delegation representing ... had a strong showing at AUVSI,s Unmanned 2015 conference last ... Ohio,s UAS industry met with over ... all points along the UAS ecosystem. "Our ... Vice President for Aerospace Rich Knoll . "If you ...
    (Date:5/6/2015)... 2015 LifeBEAM, a developer of bio-sensing technology, ... today that they will expand their partnership in bio-sensing ... cycling helmet and the first joint project between the ... in order to give cyclists more style choices and ... and Lazer announced their plan to release a new ...
    Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
    ... developed a 3D filming technique that could help inform research ... digital holograms of malaria sperm has given researchers fresh insights ... Understanding how malaria parasites mate could pave the way ... poses a threat to half of the world,s population. ...
    ... This news release is available in German . ... assess the global impacts of land use on the environment ... the leadership of the Helmholtz Centre for Environmental Research (UFZ) ... Based on various indicators of land-use intensity, climate, environmental and ...
    ... Awards acknowledges projects that aim for the development ... the awards distinguished with honorable mentions the Initiative ... tracks Mobilization Initiative of Sic Notcias and Information ... collaborations with MIT Portugal Program, in partnership with ...
    Cached Biology News:Global map provides new insights into land use 2Global map provides new insights into land use 3MIT Portugal is a partner of 2 projects distinguished by the Green Project Awards 2
    (Date:5/21/2015)... St. Louis, MO (PRWEB) May 21, 2015 ... that assesses the safety and efficacy of pharmaceutical products ... Access Drive Maryland Heights, MO 63043, a 50,000 sq. ... their current location, to enable strategic growth. Facility renovations ... offices to the new space will occur in September. ...
    (Date:5/21/2015)... -- Prima Biomed Ltd. (NASDAQ: PBMD ) a globally ... leader in the development of immunotherapeutic products for the ... data from the Phase II CAN-003 ovarian cancer clinical ... meaningful improvement in Overall Survival ("OS") over standard of ... the group of second remission patients (n=20), the median ...
    (Date:5/21/2015)... LONDON , May 21, 2015 ... your inner feelings - and those of others. Being ... and senses. Analyze and read people to anticipate their ... your deepest emotions and feelings to create unique ... generation of responsive games. Get inside a first-person-shooter as ...
    (Date:5/21/2015)...  CytRx Corporation (NASDAQ: CYTR ), a ... today announced positive updated results from its ongoing ... treatment of unresectable glioblastoma multiforme (GBM), a deadly ... is designed to investigate the preliminary efficacy and ... progressed following prior treatment with surgery, radiation and ...
    Breaking Biology Technology:Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 2Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 3Correction Continues after Big Move - BrokerBank Securities, Inc. 25 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7
    ... Ikaria, Inc., a critical care company focused on developing and ... critically ill patients in the hospital and ICU settings, today ... at the 14th Annual BIO CEO & Investor Conference.  Mr. ... at 3:30 p.m. EST in the Park South of the ...
    ... this week in Science , a Manchester team lead ... has literally opened a third dimension in graphene research. Their ... for graphene to become the next silicon. Graphene ... material with endless unique properties, from electronic to chemical and ...
    ... (NASDAQ: ITMN ) today announced that it will ... at the close of the U.S. markets on Thursday, February ... hosted by InterMune at 4:30 p.m. Eastern time that same ... the conference call by dialing 800-891-8257 (U.S.) or +1-212-271-4651 (international), ...
    Cached Biology Technology:Ikaria® to Present at 14th Annual BIO CEO & Investor Conference 2Graphene electronics moves into a third dimension 2InterMune to Release Fourth Quarter and Full Year Financial Results on February 9 2
    Immunogen: Synthetic peptide: S(399) P W S E L E F Q F P D D K D P V W E F(418) Storage: -20 C, Avoid Freeze/Thaw Cycles...
    Immunogen: C terminus [VQLKRSKNDSKPYC] of cardiac elav-type RNA-binding protein (ETR-3) Storage: -20 C, Avoid Freeze/Thaw Cycles...
    Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
    ... FP Standardization Kit is used to ... polarization values of fluorescein solutions to ... System. It also allows users to ... their instrument to the expected values ...
    Biology Products: